Keywords: AstraZeneca, Fourth-quarter and full-year 2010 financial results

Strong Crestor sales boost AstraZeneca 2010 results

Article | 27 January 2011

Print This

Anglo-Swedish drug major AstraZeneca (LSE: AZN) reported a 2% rise in annual pretax profits to $10.98 billion - helped by higher sales ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in